Proteolytic degradation of amyloid β-protein

Takaomi Saido, Malcolm A. Leissring

Research output: Contribution to journalArticle

173 Citations (Scopus)

Abstract

The amyloid β-protein (Aβ) is subject to proteolytic degradation by a diverse array of peptidases and proteinases, known collectively as Aβ-degrading proteases (AβDPs). A growing number of AβDPs have been identified, which, under physiological and/or pathophysiological conditions, contribute significantly to the determination of endogenous cerebral Aβ levels. Despite more than a decade of investigation, the complete set of AβDPs remains to be established, and our understanding of even well-established AβDPs is incomplete. Nevertheless, the study of known AβDPs has contributed importantly to our understanding of the molecular pathogenesis of Alzheimer disease (AD) and has inspired the development of several novel therapeutic approaches to the regulation of cerebral Aβ levels. In this article, we discuss the general features of Aβ degradation and introduce the best-characterized AβDPs, focusing on their diverse properties and the numerous conceptual insights that have emerged from the study of each.

Original languageEnglish (US)
Article numbera006379
JournalCold Spring Harbor perspectives in medicine
Volume2
Issue number6
DOIs
StatePublished - 2012

Fingerprint

Amyloidogenic Proteins
Peptide Hydrolases
Degradation
Serum Amyloid A Protein
Alzheimer Disease

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Proteolytic degradation of amyloid β-protein. / Saido, Takaomi; Leissring, Malcolm A.

In: Cold Spring Harbor perspectives in medicine, Vol. 2, No. 6, a006379, 2012.

Research output: Contribution to journalArticle

Saido, Takaomi ; Leissring, Malcolm A. / Proteolytic degradation of amyloid β-protein. In: Cold Spring Harbor perspectives in medicine. 2012 ; Vol. 2, No. 6.
@article{f7b2702c75ef47d387fed525306b1178,
title = "Proteolytic degradation of amyloid β-protein",
abstract = "The amyloid β-protein (Aβ) is subject to proteolytic degradation by a diverse array of peptidases and proteinases, known collectively as Aβ-degrading proteases (AβDPs). A growing number of AβDPs have been identified, which, under physiological and/or pathophysiological conditions, contribute significantly to the determination of endogenous cerebral Aβ levels. Despite more than a decade of investigation, the complete set of AβDPs remains to be established, and our understanding of even well-established AβDPs is incomplete. Nevertheless, the study of known AβDPs has contributed importantly to our understanding of the molecular pathogenesis of Alzheimer disease (AD) and has inspired the development of several novel therapeutic approaches to the regulation of cerebral Aβ levels. In this article, we discuss the general features of Aβ degradation and introduce the best-characterized AβDPs, focusing on their diverse properties and the numerous conceptual insights that have emerged from the study of each.",
author = "Takaomi Saido and Leissring, {Malcolm A.}",
year = "2012",
doi = "10.1101/cshperspect.a006379",
language = "English (US)",
volume = "2",
journal = "Cold Spring Harbor perspectives in medicine",
issn = "2157-1422",
publisher = "Cold Spring Harbor Laboratory Press",
number = "6",

}

TY - JOUR

T1 - Proteolytic degradation of amyloid β-protein

AU - Saido, Takaomi

AU - Leissring, Malcolm A.

PY - 2012

Y1 - 2012

N2 - The amyloid β-protein (Aβ) is subject to proteolytic degradation by a diverse array of peptidases and proteinases, known collectively as Aβ-degrading proteases (AβDPs). A growing number of AβDPs have been identified, which, under physiological and/or pathophysiological conditions, contribute significantly to the determination of endogenous cerebral Aβ levels. Despite more than a decade of investigation, the complete set of AβDPs remains to be established, and our understanding of even well-established AβDPs is incomplete. Nevertheless, the study of known AβDPs has contributed importantly to our understanding of the molecular pathogenesis of Alzheimer disease (AD) and has inspired the development of several novel therapeutic approaches to the regulation of cerebral Aβ levels. In this article, we discuss the general features of Aβ degradation and introduce the best-characterized AβDPs, focusing on their diverse properties and the numerous conceptual insights that have emerged from the study of each.

AB - The amyloid β-protein (Aβ) is subject to proteolytic degradation by a diverse array of peptidases and proteinases, known collectively as Aβ-degrading proteases (AβDPs). A growing number of AβDPs have been identified, which, under physiological and/or pathophysiological conditions, contribute significantly to the determination of endogenous cerebral Aβ levels. Despite more than a decade of investigation, the complete set of AβDPs remains to be established, and our understanding of even well-established AβDPs is incomplete. Nevertheless, the study of known AβDPs has contributed importantly to our understanding of the molecular pathogenesis of Alzheimer disease (AD) and has inspired the development of several novel therapeutic approaches to the regulation of cerebral Aβ levels. In this article, we discuss the general features of Aβ degradation and introduce the best-characterized AβDPs, focusing on their diverse properties and the numerous conceptual insights that have emerged from the study of each.

UR - http://www.scopus.com/inward/record.url?scp=84864755408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864755408&partnerID=8YFLogxK

U2 - 10.1101/cshperspect.a006379

DO - 10.1101/cshperspect.a006379

M3 - Article

C2 - 22675659

AN - SCOPUS:84864755408

VL - 2

JO - Cold Spring Harbor perspectives in medicine

JF - Cold Spring Harbor perspectives in medicine

SN - 2157-1422

IS - 6

M1 - a006379

ER -